127 related articles for article (PubMed ID: 28364921)
1. The people factor: An analysis of the human resources landscape for immunization supply chain management.
Kasonde M; Steele P
Vaccine; 2017 Apr; 35(17):2134-2140. PubMed ID: 28364921
[TBL] [Abstract][Full Text] [Related]
2. Understanding the policy environment for immunization supply chains: Lessons learned from landscape analyses in Uganda and Senegal.
Luzze H; Badiane O; Mamadou Ndiaye EH; Ndiaye AS; Atuhaire B; Atuhebwe P; Guinot P; Fry Sosne E; Gueye A
Vaccine; 2017 Apr; 35(17):2141-2147. PubMed ID: 28364922
[TBL] [Abstract][Full Text] [Related]
3. National logistics working groups: A landscape analysis study.
Leab D; Schreiber B; Kasonde M; Bessat O; Bui S; Loisel C
Vaccine; 2017 Apr; 35(17):2233-2242. PubMed ID: 28364937
[TBL] [Abstract][Full Text] [Related]
4. Costs of vaccine programs across 94 low- and middle-income countries.
Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
[TBL] [Abstract][Full Text] [Related]
5. The imperative for stronger vaccine supply and logistics systems.
Zaffran M; Vandelaer J; Kristensen D; Melgaard B; Yadav P; Antwi-Agyei KO; Lasher H
Vaccine; 2013 Apr; 31 Suppl 2():B73-80. PubMed ID: 23598495
[TBL] [Abstract][Full Text] [Related]
6. Seizing market shaping opportunities for vaccine cold chain equipment.
Azimi T; Franzel L; Probst N
Vaccine; 2017 Apr; 35(17):2260-2264. PubMed ID: 28364940
[TBL] [Abstract][Full Text] [Related]
7. System redesign of the immunization supply chain: Experiences from Benin and Mozambique.
Prosser W; Jaillard P; Assy E; Brown ST; Matsinhe G; Dekoun M; Lee BY
Vaccine; 2017 Apr; 35(17):2162-2166. PubMed ID: 28364925
[TBL] [Abstract][Full Text] [Related]
8. Transforming vaccines supply chains in Nigeria.
Sarley D; Mahmud M; Idris J; Osunkiyesi M; Dibosa-Osadolor O; Okebukola P; Wiwa O
Vaccine; 2017 Apr; 35(17):2167-2174. PubMed ID: 28364926
[TBL] [Abstract][Full Text] [Related]
9. Ensuring vaccine potency and availability: how evidence shaped Gavi's Immunization Supply Chain Strategy.
Prosser W; Sagar K; Seidel M; Alva S
BMC Health Serv Res; 2022 Oct; 22(1):1237. PubMed ID: 36207724
[TBL] [Abstract][Full Text] [Related]
10. The GAVI Financing Task Force: one model of partner collaboration.
Milstien JB; Kamara L; Lydon P; Mitchell V; Landry S
Vaccine; 2008 Dec; 26(51):6699-705. PubMed ID: 19306508
[TBL] [Abstract][Full Text] [Related]
11. New vaccine introduction in the East and Southern African sub-region of the WHO African region in the context of GIVS and MDGs.
Chauke-Moagi BE; Mumba M
Vaccine; 2012 Sep; 30 Suppl 3():C3-8. PubMed ID: 22939018
[TBL] [Abstract][Full Text] [Related]
12. Professional changes induced by a redesigned immunization supply chain in the Comé Health Zone, Benin.
Guillermet E; Alfa DA; Gbodja R; Jaillard P
Vaccine; 2017 Apr; 35(17):2189-2194. PubMed ID: 28364929
[TBL] [Abstract][Full Text] [Related]
13. Challenges to sustainable immunization systems in Gavi transitioning countries.
Cernuschi T; Gaglione S; Bozzani F
Vaccine; 2018 Oct; 36(45):6858-6866. PubMed ID: 30268735
[TBL] [Abstract][Full Text] [Related]
14. How much does it cost to get a dose of vaccine to the service delivery location? Empirical evidence from Vietnam's Expanded Program on Immunization.
Mvundura M; Kien VD; Nga NT; Robertson J; Cuong NV; Tung HT; Hong DT; Levin C
Vaccine; 2014 Feb; 32(7):834-8. PubMed ID: 24370713
[TBL] [Abstract][Full Text] [Related]
15. Transforming cold chain performance and management in lower-income countries.
Brison M; LeTallec Y
Vaccine; 2017 Apr; 35(17):2107-2109. PubMed ID: 28364916
[TBL] [Abstract][Full Text] [Related]
16. Developing and sustaining human resources in the health supply chain in Ethiopia: barriers and enablers.
Kälvemark Sporrong S; Traulsen JM; Damene Kabtimer W; Mekasha Habtegiorgis B; Teshome Gebregeorgise D; Essah NA; Khan SA; Brown AN
Rural Remote Health; 2016; 16(3):3613. PubMed ID: 27487268
[TBL] [Abstract][Full Text] [Related]
17. Role of Global Alliance for Vaccines and Immunization (GAVI) in Accelerating Inactivated Polio Vaccine Introduction.
Thacker N; Thacker D; Pathak A
Indian Pediatr; 2016 Aug; 53 Suppl 1():S57-S60. PubMed ID: 27771641
[TBL] [Abstract][Full Text] [Related]
18. Equity and immunization supply chain in Madagascar.
van den Ent MMVX; Yameogo A; Ribaira E; Hanson CM; Ratoto R; Rasolomanana S; Foncha C; Gasse F
Vaccine; 2017 Apr; 35(17):2148-2154. PubMed ID: 28364923
[TBL] [Abstract][Full Text] [Related]
19. Improving iSC performance through outsourcing - Considerations for using third-party service providers to increase innovation, capacity and efficiency.
Wright M; Forster G; Beale J
Vaccine; 2017 Apr; 35(17):2195-2197. PubMed ID: 28364930
[TBL] [Abstract][Full Text] [Related]
20. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?
Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S
Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]